ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2012

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience.

J J Wheler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.